









Markets
/
Stocks
/
nasdaq-qsi
/

Quantum-Si Inc

QSI

1.065USD

+0.133+14.26%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

229.46MMarket Cap

LossP/E TTM



Quantum-Si Inc

1.065

+0.133+14.26%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Quantum-Si Inc

Currency: USD Updated: 2026-02-06

Key Insights

Quantum-Si Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 153 out of 392 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.67.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Quantum-Si Inc's Score

Industry at a Glance

Industry Ranking

153 / 392

Overall Ranking

298 / 4521

Industry

Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Quantum-Si Inc Highlights

StrengthsRisks

Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.

Growing

The company is in a growing phase, with the latest annual income totaling USD 3.06M.

Overvalued

The company’s latest PE is -1.60, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 61.41M shares, increasing 1.99% quarter-over-quarter.

Held by Invesco

Star Investor Invesco holds 249.02K shares of this stock.

Analyst Rating

Based on 3 analysts

Buy

Current Rating

2.667

Target Price

+186.09%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of Quantum-Si Inc is 6.00, ranking 301 out of 392 in the Biotechnology & Medical Research industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 552.00K, representing a year-over-year decrease of 29.86%, while its net profit experienced a year-over-year decrease of 41.05%.

Score

Industry at a Glance

Previous score

6.00

Change



Financials

7.07

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

7.53

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

2.83

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

5.48

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.07

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Quantum-Si Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of Quantum-Si Inc is 7.00, ranking 189 out of 392 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.60, which is -37.69% below the recent high of -1.00 and -279.24% above the recent low of -6.08.

Score

Industry at a Glance

Previous score

7.00

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 153/392

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of Quantum-Si Inc is 7.33, ranking 294 out of 392 in the Biotechnology & Medical Research industry. The average price target is 2.50, with a high of 4.00 and a low of 2.00.

Score

Industry at a Glance

Previous score

7.33

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 3 analysts

Buy

Current Rating

2.667

Target Price

+186.09%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

542

Total

Median

Average

Company name

Ratings

Analysts

Quantum-Si Inc

QSI

CRISPR Therapeutics AG

CRSP

argenx SE

ARGX

IQVIA Holdings Inc

IQV

Intellia Therapeutics Inc

NTLA

Beigene Ltd

ONC

...

109

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of Quantum-Si Inc is 6.77, ranking 173 out of 392 in the Biotechnology & Medical Research industry. Currently, the stock price is trading between the resistance level at 1.29 and the support level at 0.88, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.20

Change

0.57

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.037

Sell

RSI(14)

41.356

Neutral

STOCH(KDJ)(9,3,3)

24.411

Buy

ATR(14)

0.087

Low Volatility

CCI(14)

-99.943

Neutral

Williams %R

65.400

Sell

TRIX(12,20)

-0.577

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

1.043

Buy

MA10

1.116

Sell

MA20

1.180

Sell

MA50

1.247

Sell

MA100

1.503

Sell

MA200

1.503

Sell

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of Quantum-Si Inc is 3.00, ranking 197 out of 392 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 31.40%, representing a quarter-over-quarter increase of 4.32%. The largest institutional shareholder is The Vanguard, holding a total of 9.61M shares, representing 4.91% of shares outstanding, with 16.57% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

Rothberg (Jonathan M)

13.73M

BlackRock Institutional Trust Company, N.A.

10.47M

+4.79%

The Vanguard Group, Inc.

Star Investors

8.71M

+0.52%

ARK Investment Management LLC

Star Investors

7.62M

-4.23%

Amova Asset Management Co., Ltd.

5.22M

-7.18%

Geode Capital Management, L.L.C.

3.75M

+8.68%

Rakin (Kevin L)

2.92M

+0.23%

State Street Investment Management (US)

2.82M

+2.21%

Millennium Management LLC

2.67M

-29.35%

Northern Trust Investments, Inc.

2.26M

+0.05%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Biotechnology & Medical Research domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Quantum-Si Inc is 2.70, ranking 210 out of 392 in the Biotechnology & Medical Research industry. The company's beta value is 3.01. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.